Veracyte

Read more
Marc Stapley's photo - CEO of Veracyte

CEO

Marc Stapley

CEO Approval Rating

82/100

Founded:

2008

Status:

PublicIndependent CompanyNASDAQVCYT

VERACYTE TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Veracyte's company profile
Marc Stapley's photo - CEO of Veracyte

Marc Stapley

CEO

82/100
270
$178.8M
$157.5M
View Profile
1
Veracyte's Competitor - Interpace logo
Thomas Burnell's photo - President & CEO of Interpace

Thomas Burnell

President & CEO

87/100
89
$52.1M
$38.9M
View Profile
2
Veracyte's Competitor - Biodesix logo
Scott Hutton's photo - President & CEO of Biodesix

Scott Hutton

President & CEO

87/100
154
$324.6M
$77M
View Profile
3
Veracyte's Competitor - Agendia logo
Mark R. Straley's photo - CEO of Agendia

Mark R. Straley

CEO

86/100
137
$157M
$15M
View Profile
4
Veracyte's Competitor - Asuragen logo
Matthew McManus's photo - President & CEO of Asuragen

Matthew McManus

President & CEO

85/100
200
$82M
$30M
View Profile
5
Veracyte's Competitor - OmeCare logo
CEO Avatar

CEO

- -
32
$53M
$2M
View Profile
6
Veracyte's Competitor - AltheaDx logo
David Nikodem's photo - CEO of AltheaDx

David Nikodem

CEO

84/100
148
$87.9M
$10M
View Profile
7
Veracyte's Competitor - Proteocyte Diagnostics logo
CEO Avatar

Kenneth P. H. Pritzker

President & CEO

69/100
78
$555.2K
View Profile
8
Veracyte's Competitor - Quest Diagnostics logo
Stephen H Rusckowski's photo - Chairman & CEO of Quest Diagnostics

Stephen H Rusckowski

Chairman & CEO

85/100
46,000
- -
$11.1B
View Profile
9
Veracyte's Competitor - Autobio Diagnostics Co., Ltd. logo
CEO Avatar

Wu Xuewei

General Manager

70/100
10
- -
View Profile
10
Veracyte's Competitor - Eloquest Healthcare logo
CEO Avatar

CEO

- -
118
- -
$35.7M
View Profile
11
Veracyte's Competitor - Integrated Diagnostics logo
CEO Avatar

CEO

- -
93
$103.8M
$4.4M
View Profile
12
Veracyte's Competitor - Quest  Global Benefits logo
CEO Avatar

CEO

- -
184
- -
$34.2M
View Profile

Missing a competitor? Contribute!

Interpace is Veracyte's biggest rival. Interpace was founded in 2014, and is headquartered in Parsippany, New Jersey. Like Veracyte, Interpace also works within the Biotechnology sector. Interpace generates $118.7M less revenue vs. Veracyte.

Biodesix is one of Veracyte's top competitors. Biodesix's headquarters is in Boulder, Colorado, and was founded in 2005. Like Veracyte, Biodesix also works within the Biotechnology sector. Biodesix generates 73% of Veracyte's revenue.

Agendia is seen as one of Veracyte's top competitors. Agendia is a Private company that was founded in 2003 in Irvine, California. Agendia operates in the Biotechnology industry. Compared to Veracyte, Agendia has 133 fewer employees.

Veracyte Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$157.5M

Veracyte's revenue is the ranked 4th among it's top 10 competitors. The top 10 competitors average 935M. Over the last four quarters, Veracyte's revenue has grown by 77.1%. Specifically, in Q2 2021's revenue was $55.1M; in Q1 2021, it was $36.7M; in Q4 2020, it was $34.5M; in Q3 2020, Veracyte's revenue was $31.1M.

Veracyte Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
HalioDx SAS

Jun 2021

Source »
$317.4M
HalioDx is a France-based immuno-oncology diagnostics company that provides immune assessment, clinical trial testing and related solutions for drug development organizations.
Decipher Biosciences, Inc.

Feb 2021

Source »
$600M
Decipher Biosciences is a California-based biotechnology company that develops and commercializes genomic assays for the treatment of urologic cancer.
Allegro Diagnostics Corp.

Sep 2014

Source »
$21M
Allegro Diagnostics engages in the development and commercialization of genomic tests.

These are all the companies that Veracyte has acquired. Veracyte has acquired 3 companies and its latest acquisition was HalioDx SAS in Jun 2021. HalioDx is a France-based immuno-oncology diagnostics company that provides immune assessment, clinical trial testing and related solutions for drug development organizations.

Veracyte Funding History

Since Veracyte was founded in 2008, it has participated in 5 rounds of funding. In total Veracyte has raised $178.8M. Veracyte's last funding round was on Mar 2016 for a total of $45.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt
Mar 2016
$45M
Equity
Sep 2014
$12.8M
IPO
Oct 2013
$65M
-
Series C
Jun 2013
$28M
Series B
Jun 2010
$28M

Since Veracyte was founded in 2008, it has participated in 5 rounds of funding. In total Veracyte has raised $178.8M. Veracyte's last funding round was on Mar 2016 for a total of $45.0M

Veracyte Investments

No recent investments found related to Veracyte

Veracyte News

August 4, 2021MarketScreener

Consent of Fenwick & West LLP (contained in Exhibit 5.1) (Form 8-K)

(marketscreener.com) August 4, 2021 Veracyte, Inc. 6000 Shoreline Court, Suite 300 South San Francisc... See more »
July 30, 2021Genomeweb

Veracyte Aims to Broaden Reach of Decipher Prostate Assay as Studies Continue to Expand Utility

The company reported significant momentum in test volumes for the second quarter of this year as new ... See more »
July 29, 2021MarketScreener

Announces Second Quarter 2021 Financial Results

(marketscreener.com) Total Revenue Increased 166% to $55.1 million; Genomic Volume Grew 215% to 20,85... See more »
July 27, 2021MarketScreener

New Study Suggests Decipher Prostate Biopsy Test May Help Guide Use of Active Surveillance in Prostate Cancer

(marketscreener.com) Real-world data suggest Decipher test's risk scores are independently associated... See more »
July 13, 2021MarketScreener

Material Definitive Agreement (Form 8-K)

(marketscreener.com) Entry into a Material Definitive Agreement. On July 13, 2021, Veracyte, Inc. ent... See more »
July 8, 2021MarketScreener

Announces Key Appointments to Executive Leadership Team, Supporting Global Expansion

(marketscreener.com) Rob Brainin Named Executive Vice President and Chief Business Officer; Bill Zond... See more »

Veracyte Press Releases

April 14, 2021Business Wire

Veracyte Announces Key Milestone in Companion Diagnostics Program With Acerta Pharma Using LymphMark Lymphoma Subtyping Test

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--The first patient has been enrolled and randomized in A... See more »
November 23, 2020Business Wire

Veracyte to Participate in Piper Sandler 32nd Annual Virtual Healthcare Conference

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte to Participate in Piper Sandler 32nd Annual Vi... See more »
October 22, 2020Business Wire

Veracyte Announces Publication of Manuscript Describing Scientific Rigor Behind Next-Generation Percepta Genomic Sequencing Classifier

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte Announces Publication of Manuscript Describing... See more »
October 14, 2020Business Wire

Veracyte Announces Two Presentations to Be Shared at CHEST Annual Meeting 2020

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte Announces Two Presentations to Be Shared at CH... See more »
August 24, 2020Business Wire

Veracyte Named a San Francisco Bay Area "Top Workplace" for Seventh Consecutive Year

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading genomic diagno... See more »

Veracyte Videos

Social Media

Veracyte Headquarters

6000 Shoreline Court Suite 300

South San Francisco, California94080

1-650-243-6335

Driving Directions »

Trending Companies

Veracyte Summary

ABOUT

Overview

Veracyte is a California-based genomic diagnostics company that develops molecular diagnostic tests for the healthcare industry. Veracyte was founded in 2008. Veracyte's headquarters is located in South San Francisco, California, USA 94080. It has rai...

CEO

Veracyte's CEO, Marc Stapley, currently has an approval rating of 82%. Veracyte's primary competitors are Interpace, Biodesix & Agendia.

Frequently Asked Questions about Veracyte

  1. When was Veracyte founded?

    Veracyte was founded in 2008
  2. Who is Veracyte's CEO?

    Veracyte's CEO is Marc Stapley
  3. How much revenue does Veracyte generate?

    Veracyte generates $157.5M in revenue
  4. How much funding does Veracyte have?

    Veracyte has historically raised $178.8M in funding
  1. Where is Veracyte's headquarters?

    Veracyte's headquarters is in South San Francisco California, USA
  2. How many employees does Veracyte have?

    Veracyte has 270 employees
  3. What sector does Veracyte operate in?

    Veracyte is in Pharmaceuticals, Biotechnology
  4. Who are Veracyte's competitors?

    Veracyte's top competitors are Interpace, Biodesix, Agendia